Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
77,639.99
(
0.22%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: None

Wednesday, 02/16/2011 3:53:26 PM

Wednesday, February 16, 2011 3:53:26 PM

Post# of 257443
Anyone here have any views on the prospects for GSK's platelet booster Promacta?

GSK has it in two Phase III trials as an add-on to Pegasys/Pegintron + Ribavirin in HCV. Phase II data showed a substantial increase in number of patients completing therapy (claim is 65% vs 6%).

Peter

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today